MissonAboutPartner Contact us Privacy Policy

Companies | B2B

CompaniesServicesBrands / SuppliersProductsLabels and ScoresSupplier Sourcing
Result is based on your search and filter criteria (except counts). It may be possible that the information is wholly or partly outdated, incomplete or no longer correct
Yuki Cheeze Yuki Cheeze is founded with a clear mission: to provide a healthy and sustainable alternative to traditional dairy products while reducing our impact on the environment. We favor local and sustainable ingredients, such as Swiss soy milk, Italian almonds and Swiss Alpine salt. Additionally, our packaging is climate neutral, plastic-free, fully compostable, reusable or recyclable. Our ultimate goal is to move towards zero waste.
Emulate Our Human Emulation System provides a high-fidelity window into the inner workings of human biology and disease.
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro models that empower researchers to explore the biological mechanisms of health and disease.
AlveoliX AlveoliX provides advanced in-vitro models, called Organs-on-Chip. These models are used to better predict human responses in preclinical drug development and to gain more insight into human biology.

AlveoliX’s mission is to make organs-on-chips the new standard for preclinical decision-making and the leading alternative to animal experiments. With our technology, we reproduce the microenvironment of human organs in an unprecedented way.
Newcells Biotech Newcells Biotech uses 3D in vitro modelling expertise to develop nephrotoxicity and renal transporter assays that most accurately predict in vivo outcomes, as well as producing fully developed hiPSC-derived Retinal Organoids.
NETRI NETRI is an industrial start-up developing innovative technologies for the pharmaceutical industry. Its patented organs-on-chip technologies allow the creation of standardized and predictive human in vitro models.
Ncardia For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).
MIMETAS Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.
MEPSGEN Advanced microfluidic technologies for Nanomedicine Development. We develop and employ human microphysiological systems or organ-on-a-chip to better predict drug toxicity and efficacy.
Lena Biosciences Lena Biosciences offers Perfused Organ Panel MPS with a Blood Substitute hemoglobin analog that yields a log-fold increase in CYP450 activity in primary human hepatocytes to identify mitotoxic metabolites and DILI. Services focus on efficacy and toxicity in liver, brain, tumor, and blood models.
Kiyatec KIYATEC’s clinically validated, predictive 3D ex vivo assays characterize response to I/O, targeted, and chemo therapies. Data from our proprietary platforms span most solid tumors including ovarian, GBM, breast, & rare. Our services cover all phases of preclinical development thru clinical trials.
Hesperos The Human-on-a-Chip Company
Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.
CN Bio CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines
Draper Draper is an independent engineering innovation company. We re-imagine and engineer biomedical solutions that improve health outcomes and set a new pace and effectiveness for medical innovation for our pharma and healthcare partners. We are a leader in organ-on-chip and microphysiological systems
AxoSim AxoSim is a premier provider of neurological drug discovery platforms. The company’s proprietary BrainSim™ and NerveSim™ platforms provide accurate, predictive models of the peripheral and central nervous systems, delivering clinically-actionable human data early in the drug development process.
Upfield People around the world are embracing plant-based foods for both health and ethical reasons. Our vision for a “Better Plant-Based Future” drives positive change in people’s health, their daily lives and our planet’s sustainability. In our main plant-based categories of butters & spreads, creams, liquids and cheeses, we have developed great-tasting products, that taste and perform as well as animal-based, but are made from plants. We believe that this is the future of food: food that is healthier
Dreamfarm Where plant-based dreams are grown.
100% made in Italy!
Mondarella Plant-based cheese redefined. Super tasty, clean label, high nutritional value - cheese craft meets bio-tech.
Lütolf Our core business is the storage and processing of grain. Building on the core business, additional business areas such as the production of semi-finished products in the liquid sector and the production and marketing of food specialties have been added over the years.